Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatments

Physicians expect a treatment to be more effective when its clinical outcomes are described as relative rather than as absolute risk reductions. We examined whether effects of presentation method (relative vs. absolute risk reduction) remain when physicians are provided the baseline risk information...

Full description

Bibliographic Details
Main Authors: Francesco Marcatto, Jonathan J. Rolison, Donatella Ferrante
Format: Article
Language:English
Published: Cambridge University Press 2013-01-01
Series:Judgment and Decision Making
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S1930297500004472/type/journal_article
_version_ 1797701680619323392
author Francesco Marcatto
Jonathan J. Rolison
Donatella Ferrante
author_facet Francesco Marcatto
Jonathan J. Rolison
Donatella Ferrante
author_sort Francesco Marcatto
collection DOAJ
description Physicians expect a treatment to be more effective when its clinical outcomes are described as relative rather than as absolute risk reductions. We examined whether effects of presentation method (relative vs. absolute risk reduction) remain when physicians are provided the baseline risk information, a vital piece of statistical information omitted in previous studies. Using a between-subjects design, ninety five physicians were presented the risk reduction associated with a fictitious treatment for hypertension either as an absolute risk reduction or as a relative risk reduction, with or without including baseline risk information. Physicians reported that the treatment would be more effective and that they would be more willing to prescribe it when its risk reduction was presented to them in relative rather than in absolute terms. The relative risk reduction was perceived as more effective than absolute risk reduction even when the baseline risk information was explicitly reported. We recommend that information about absolute risk reduction be made available to physicians in the reporting of clinical outcomes. Moreover, health professionals should be cognizant of the potential biasing effects of risk information presented in relative risk terms.
first_indexed 2024-03-12T04:40:11Z
format Article
id doaj.art-9930ddc3434b46ba8ce85eeacf968c75
institution Directory Open Access Journal
issn 1930-2975
language English
last_indexed 2024-03-12T04:40:11Z
publishDate 2013-01-01
publisher Cambridge University Press
record_format Article
series Judgment and Decision Making
spelling doaj.art-9930ddc3434b46ba8ce85eeacf968c752023-09-03T09:45:49ZengCambridge University PressJudgment and Decision Making1930-29752013-01-018293310.1017/S1930297500004472Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatmentsFrancesco Marcatto0Jonathan J. Rolison1Donatella Ferrante2Department of Life Sciences, University of Trieste, Via Weiss 21, 34138, Trieste, ItalyDepartment of Psychology, Queen’s University Belfast, UKDepartment of Life Sciences, University of Trieste, ItalyPhysicians expect a treatment to be more effective when its clinical outcomes are described as relative rather than as absolute risk reductions. We examined whether effects of presentation method (relative vs. absolute risk reduction) remain when physicians are provided the baseline risk information, a vital piece of statistical information omitted in previous studies. Using a between-subjects design, ninety five physicians were presented the risk reduction associated with a fictitious treatment for hypertension either as an absolute risk reduction or as a relative risk reduction, with or without including baseline risk information. Physicians reported that the treatment would be more effective and that they would be more willing to prescribe it when its risk reduction was presented to them in relative rather than in absolute terms. The relative risk reduction was perceived as more effective than absolute risk reduction even when the baseline risk information was explicitly reported. We recommend that information about absolute risk reduction be made available to physicians in the reporting of clinical outcomes. Moreover, health professionals should be cognizant of the potential biasing effects of risk information presented in relative risk terms.https://www.cambridge.org/core/product/identifier/S1930297500004472/type/journal_articlerelative riskabsolute riskbaseline riskrisk communicationpresentation format
spellingShingle Francesco Marcatto
Jonathan J. Rolison
Donatella Ferrante
Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatments
Judgment and Decision Making
relative risk
absolute risk
baseline risk
risk communication
presentation format
title Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatments
title_full Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatments
title_fullStr Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatments
title_full_unstemmed Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatments
title_short Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatments
title_sort communicating clinical trial outcomes effects of presentation method on physicians evaluations of new treatments
topic relative risk
absolute risk
baseline risk
risk communication
presentation format
url https://www.cambridge.org/core/product/identifier/S1930297500004472/type/journal_article
work_keys_str_mv AT francescomarcatto communicatingclinicaltrialoutcomeseffectsofpresentationmethodonphysiciansevaluationsofnewtreatments
AT jonathanjrolison communicatingclinicaltrialoutcomeseffectsofpresentationmethodonphysiciansevaluationsofnewtreatments
AT donatellaferrante communicatingclinicaltrialoutcomeseffectsofpresentationmethodonphysiciansevaluationsofnewtreatments